Tumour-stroma ratio to predict pathological response to neo-adjuvant treatment in rectal cancer

Management of rectal cancer has advanced, with an increasing use of neoadjuvant chemoradiotherapy (nCRT). This opens options for organ preserving treatment for those with a major response to nCRT. However, the degree of clinical response, based on MRI and post-treatment biopsies, only poorly matches...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgical oncology 2022-12, Vol.45, p.101862-101862, Article 101862
Hauptverfasser: Strous, M.T.A., Faes, T.K.E., Heemskerk, J., Lohman, B.G.P.M., Simons, P.C.G., Janssen Heijnen, M.L.G., Vogelaar, F.J., de Bruïne, A.P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!